MoneyWorks4Me

Dr. Reddy's gets EIR for formulations manufacturing facility in Andhra Pradesh

23 Oct 2025 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) on October 20, 2025 for its formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh, India. 

The United States Food & Drug Administration (USFDA) has classified the inspection outcome as 'Voluntary Action Indicated (VAI)' and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..